SG43009A1 - Stem cell factor - Google Patents
Stem cell factorInfo
- Publication number
- SG43009A1 SG43009A1 SG1996002213A SG1996002213A SG43009A1 SG 43009 A1 SG43009 A1 SG 43009A1 SG 1996002213 A SG1996002213 A SG 1996002213A SG 1996002213 A SG1996002213 A SG 1996002213A SG 43009 A1 SG43009 A1 SG 43009A1
- Authority
- SG
- Singapore
- Prior art keywords
- scf
- dna sequence
- stem cell
- cell factor
- biological activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Hall/Mr Elements (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42238389A | 1989-10-16 | 1989-10-16 | |
US53719890A | 1990-06-11 | 1990-06-11 | |
US57361690A | 1990-08-24 | 1990-08-24 | |
PCT/US1990/005548 WO1991005795A1 (en) | 1989-10-16 | 1990-09-28 | Stem cell factor |
US58970190A | 1990-10-01 | 1990-10-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG43009A1 true SG43009A1 (en) | 1997-10-17 |
Family
ID=27503703
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG1996002213A SG43009A1 (en) | 1989-10-16 | 1990-10-04 | Stem cell factor |
SG1996001817A SG59931A1 (en) | 1989-10-16 | 1990-10-04 | Stem cell factor |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG1996001817A SG59931A1 (en) | 1989-10-16 | 1990-10-04 | Stem cell factor |
Country Status (11)
Country | Link |
---|---|
US (3) | US6218148B1 (zh) |
EP (4) | EP0992579B1 (zh) |
CN (2) | CN1289526C (zh) |
AT (2) | ATE194651T1 (zh) |
CZ (3) | CZ286304B6 (zh) |
DE (2) | DE69034258D1 (zh) |
DK (1) | DK0423980T3 (zh) |
GR (1) | GR3034559T3 (zh) |
HK (1) | HK1010397A1 (zh) |
SG (2) | SG43009A1 (zh) |
SK (2) | SK281487B6 (zh) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6759215B1 (en) * | 1989-10-16 | 2004-07-06 | Amgen Inc. | Method of preparing human stem cell factor polypeptide |
EP0536317A1 (en) * | 1990-06-25 | 1993-04-14 | Immunex Corporation | Mast cell growth factor |
US5767074A (en) * | 1990-08-27 | 1998-06-16 | Sloan-Kettering Institute For Cancer Research | Compositions of soluble C-kit ligand and hematopoietic factors |
US20030125519A1 (en) * | 1990-08-27 | 2003-07-03 | Peter Besmer | Ligand for the c-kit receptor and methods of use thereof |
US20050276784A1 (en) * | 1990-08-27 | 2005-12-15 | Solan-Kettering Institute For Cancer Research | Ligand for the c-kit receptor and methods of use thereof |
DE4224050A1 (de) * | 1991-07-31 | 1993-02-04 | Hoffmann La Roche | Loesliche kit-liganden |
US6001803A (en) * | 1992-04-23 | 1999-12-14 | Sloan-Kettering Institute For Cancer Research | Composition of c-kit ligand, GM-CSF, and TNF-α and method of use |
CA2133982C (en) * | 1992-04-23 | 2008-02-12 | Peter Besmer | Ligand for the c-kit receptor and methods of use thereof |
US6288030B1 (en) | 1993-12-22 | 2001-09-11 | Amgen Inc. | Stem cell factor formulations and methods |
US5525708A (en) * | 1994-03-28 | 1996-06-11 | Cytomed, Inc. | Covalent dimer of kit ligand |
DE69534324T2 (de) | 1994-11-04 | 2006-01-05 | Applied Research Systems Ars Holding N.V. | Menschliche scf, eine spleissvariante davon,ihre pharmazeutische verwendung |
US5824789A (en) * | 1995-06-07 | 1998-10-20 | Systemix, Inc. | Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof |
US5731284A (en) * | 1995-09-28 | 1998-03-24 | Amgen Inc. | Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product |
US6184200B1 (en) | 1995-09-28 | 2001-02-06 | Amgen Inc. | Truncated glial cell line-derived neurotrophic factor |
BR9610802A (pt) | 1995-10-04 | 1999-07-13 | Immunex Corp | Método para melhoria da resposta imunológica método de preparo de células t de antígeno específico método para induzir tolerância de tecido de enxerto auxiliar de vacina meio de expansão e preparação de células dentríticas população de células dentríticas e respectivo método de preparo método para direcionar células-tronco hematopoiéticas ou células progenitoras a uma linhagem de células dentríticas |
US5641749A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
US5641750A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
US5741778A (en) * | 1996-03-19 | 1998-04-21 | Amgen Inc. | Method for treating Huntington's disease using glial cell line-derived neurotrophic factor (GDNF) protein product |
US5885962A (en) * | 1996-04-05 | 1999-03-23 | Amgen Inc. | Stem cell factor analog compositions and method |
WO1998006422A1 (fr) | 1996-08-13 | 1998-02-19 | Fujisawa Pharmaceutical Co., Ltd. | Agents de proliferation des cellules souches hematopoietiques |
US6967092B1 (en) | 1996-10-25 | 2005-11-22 | Mc Kearn John P | Multi-functional chimeric hematopoietic receptor agonists |
US5969105A (en) * | 1996-10-25 | 1999-10-19 | Feng; Yiqing | Stem cell factor receptor agonists |
JPH10158188A (ja) * | 1996-11-29 | 1998-06-16 | Senju Pharmaceut Co Ltd | 角膜治療用組成物 |
DE60044945D1 (de) * | 1999-12-23 | 2010-10-21 | Univ Geneve | Auf scf peptid basiertes basolaterales sortiersignal und inhibitoren dafür |
US7767197B2 (en) | 2000-06-22 | 2010-08-03 | Endo Pharmaceuticals Colorado LLC | Delivery vehicle composition and methods for delivering antigens and other drugs |
US6875441B2 (en) * | 2000-06-26 | 2005-04-05 | Rxkinetix, Inc. | Composition for delivery of hematopoietic growth factor |
JP2004529740A (ja) * | 2001-06-15 | 2004-09-30 | ジョーンズ ホプキンズ シンガポール ピーティーイー リミテッド | 生体機能繊維 |
AU2002363322A1 (en) * | 2001-10-26 | 2003-05-19 | Large Scale Biology Corporation | Endothelial cell derived hemotopoietic growth factor |
EP1451332B1 (en) * | 2001-11-27 | 2008-02-13 | neXyte AB | Production of eukaryotic proteins and nucleic acid molecules in c. elegans |
WO2004071523A1 (en) * | 2003-02-14 | 2004-08-26 | Istituto Superiore Di Sanita | Stem cell factor for preventing chemotherapy-induced depletion of blood cells |
CN100345971C (zh) * | 2003-07-14 | 2007-10-31 | 第二军医大学免疫学研究所 | 重组人干细胞因子的原核表达载体、工程菌及制备方法 |
AU2004299457B2 (en) | 2003-12-12 | 2011-03-24 | Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services | A human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 |
WO2006002344A1 (en) * | 2004-06-23 | 2006-01-05 | Epigenomics Ag | Methods and nucleic acids for the detection of metastasis of colon cell proliferative disorders |
EP1773981A1 (en) * | 2004-07-12 | 2007-04-18 | Sorin Group Italia S.R.L. | Device and method for growing human cells |
ATE544463T1 (de) | 2004-11-05 | 2012-02-15 | Univ Northwestern | Verwendung von scf und g-scf bei der behandlung von hirnischämie und neurologischen störungen |
MX2007015476A (es) | 2005-06-14 | 2008-02-25 | Amgen Inc | Formulaciones de proteina autoamortiguadoras. |
CA2915270C (en) * | 2005-08-05 | 2017-07-11 | Amgen Inc. | Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
US8404653B2 (en) * | 2005-11-14 | 2013-03-26 | Enterprise Partners Venture Capital | Membrane bound stem cell factor therapy for ischemic heart |
WO2007102814A2 (en) * | 2006-03-07 | 2007-09-13 | Regenetech, Inc. | Recombinant mammalian molecules and method for production thereof |
WO2007109583A2 (en) | 2006-03-17 | 2007-09-27 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject |
EP3424507A1 (en) * | 2006-03-24 | 2019-01-09 | Children's Medical Center Corporation | Method to modulate hematopoietic stem cell growth |
WO2007137300A2 (en) | 2006-05-23 | 2007-11-29 | Bellicum Pharmaceuticals, Inc. | Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods |
EP1872790A1 (en) | 2006-06-26 | 2008-01-02 | DeveloGen Aktiengesellschaft | New formulation for increasing bioavailability of neurturin |
MX2009004164A (es) | 2006-10-20 | 2009-10-13 | Childrens Medical Center | Metodo para aumentar la regeneracion de tejido. |
EP4335863A3 (en) | 2007-07-09 | 2024-07-24 | Genentech, Inc. | Prevention of disulfide bond reduction during recombinant production of polypeptides |
WO2009155041A2 (en) * | 2008-05-28 | 2009-12-23 | Children's Medical Center Corporation | Method to modulate hematopoietic stem cell growth |
EP2351599A4 (en) | 2008-11-14 | 2013-05-08 | Dnavec Corp | METHOD FOR MANUFACTURING DENDRITIC CELLS |
WO2010096264A2 (en) | 2009-02-03 | 2010-08-26 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
US9051548B2 (en) | 2009-02-03 | 2015-06-09 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
ES2808529T3 (es) | 2011-01-10 | 2021-03-01 | Univ Michigan Regents | Inhibidor del factor de células madre |
US20150018408A1 (en) | 2013-07-10 | 2015-01-15 | The Regents Of The University Of Michigan | Therapeutic antibodies and uses thereof |
PT2785834T (pt) | 2011-12-02 | 2020-11-13 | Fate Therapeutics Inc | Composição de células estaminais melhorada |
WO2013082241A2 (en) | 2011-12-02 | 2013-06-06 | Fate Therapeutics, Inc. | Improved methods of treating ischemia |
WO2014150602A1 (en) | 2013-03-15 | 2014-09-25 | Fate Therapeutics, Inc. | Cell potency assay for therapeutic potential |
US9889451B2 (en) | 2013-08-16 | 2018-02-13 | ADA-ES, Inc. | Method to reduce mercury, acid gas, and particulate emissions |
LT6161B (lt) | 2013-09-27 | 2015-06-25 | Uab Profarma | Granuliocitų kolonijas stimuliuojančio faktoriaus sulieti baltymai su kitais augimo faktoriais, optimaliai su kamieninių ląstelių faktoriumi, ir jų gavimo būdas |
JP6383216B2 (ja) * | 2014-08-08 | 2018-08-29 | シスメックス株式会社 | 血液分析方法、血液分析装置およびプログラム |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
CN105985424B (zh) * | 2015-01-30 | 2019-08-23 | 苏州方舟生物医药有限公司 | 一种干细胞因子功能性肽段及其应用 |
CN105749252A (zh) * | 2016-04-29 | 2016-07-13 | 南方医科大学 | Il-9作为治疗血小板缺少症的药物的应用 |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
CN108541660A (zh) * | 2018-04-24 | 2018-09-18 | 上海动物园 | 动物饲养方法、动物饲养装置及其发酵床 |
JP2021534799A (ja) * | 2018-08-27 | 2021-12-16 | ノース カロライナ ステート ユニバーシティNorth Carolina State University | 肥満細胞のアポトーシスを誘導するためにスプライススイッチングオリゴヌクレオチドを用いてKitを標的とする方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695542A (en) * | 1983-10-04 | 1987-09-22 | Dnax Research Institute Of Molecular And Cellular Biology, Inc. | cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity |
US4810643A (en) * | 1985-08-23 | 1989-03-07 | Kirin- Amgen Inc. | Production of pluripotent granulocyte colony-stimulating factor |
JPS62223126A (ja) | 1986-03-25 | 1987-10-01 | Sankyo Co Ltd | 血液幹細胞成長因子 |
US4959455A (en) | 1986-07-14 | 1990-09-25 | Genetics Institute, Inc. | Primate hematopoietic growth factors IL-3 and pharmaceutical compositions |
US4847325A (en) | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
-
1990
- 1990-10-04 SG SG1996002213A patent/SG43009A1/en unknown
- 1990-10-04 EP EP99122861A patent/EP0992579B1/en not_active Expired - Lifetime
- 1990-10-04 EP EP90310899A patent/EP0423980B1/en not_active Expired - Lifetime
- 1990-10-04 DE DE69034258T patent/DE69034258D1/de not_active Expired - Lifetime
- 1990-10-04 AT AT90310899T patent/ATE194651T1/de not_active IP Right Cessation
- 1990-10-04 DE DE69033584T patent/DE69033584T2/de not_active Expired - Lifetime
- 1990-10-04 AT AT99122861T patent/ATE403713T1/de not_active IP Right Cessation
- 1990-10-04 DK DK90310899T patent/DK0423980T3/da active
- 1990-10-04 EP EP02008587A patent/EP1241258A3/en not_active Withdrawn
- 1990-10-04 EP EP95105391A patent/EP0676470A1/en not_active Withdrawn
- 1990-10-04 SG SG1996001817A patent/SG59931A1/en unknown
- 1990-10-15 SK SK981-99A patent/SK281487B6/sk not_active IP Right Cessation
- 1990-10-15 SK SK5008-90A patent/SK281484B6/sk not_active IP Right Cessation
- 1990-10-16 CN CNB001309781A patent/CN1289526C/zh not_active Expired - Lifetime
- 1990-10-16 CN CN90109647A patent/CN1075078C/zh not_active Expired - Lifetime
-
1993
- 1993-12-21 US US08/172,329 patent/US6218148B1/en not_active Expired - Lifetime
-
1994
- 1994-11-09 US US08/336,728 patent/US6207802B1/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/482,918 patent/US6207417B1/en not_active Expired - Lifetime
-
1997
- 1997-02-18 CZ CZ1997490A patent/CZ286304B6/cs not_active IP Right Cessation
- 1997-02-18 CZ CZ1997488A patent/CZ286303B6/cs not_active IP Right Cessation
- 1997-02-18 CZ CZ1997491A patent/CZ286305B6/cs not_active IP Right Cessation
-
1998
- 1998-10-20 HK HK98111343A patent/HK1010397A1/xx not_active IP Right Cessation
-
2000
- 2000-10-04 GR GR20000402249T patent/GR3034559T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CZ286303B6 (cs) | 2000-03-15 |
US6207802B1 (en) | 2001-03-27 |
CZ48897A3 (cs) | 2000-01-12 |
SK500890A3 (en) | 2001-04-09 |
DK0423980T3 (da) | 2000-10-09 |
CN1306007A (zh) | 2001-08-01 |
EP0992579B1 (en) | 2008-08-06 |
DE69034258D1 (de) | 2008-09-18 |
EP0423980A1 (en) | 1991-04-24 |
SK281484B6 (sk) | 2001-04-09 |
CZ286305B6 (cs) | 2000-03-15 |
SK98199A3 (en) | 2001-04-09 |
CZ286304B6 (cs) | 2000-03-15 |
EP0676470A1 (en) | 1995-10-11 |
DE69033584D1 (de) | 2000-08-17 |
HK1010397A1 (en) | 1999-06-17 |
ATE194651T1 (de) | 2000-07-15 |
CN1075078C (zh) | 2001-11-21 |
GR3034559T3 (en) | 2001-01-31 |
CN1289526C (zh) | 2006-12-13 |
EP0992579A1 (en) | 2000-04-12 |
ATE403713T1 (de) | 2008-08-15 |
DE69033584T2 (de) | 2001-03-08 |
CZ49197A3 (cs) | 2000-01-12 |
SK281487B6 (sk) | 2001-04-09 |
SG59931A1 (en) | 1999-02-22 |
US6207417B1 (en) | 2001-03-27 |
CZ49097A3 (cs) | 2000-01-12 |
EP1241258A2 (en) | 2002-09-18 |
EP1241258A3 (en) | 2003-12-10 |
EP0423980B1 (en) | 2000-07-12 |
US6218148B1 (en) | 2001-04-17 |
CN1051937A (zh) | 1991-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1010397A1 (en) | Stem cell factor | |
ZA943464B (en) | Vascular endothelial growth factor 2 | |
HK1008400A1 (en) | Genetic modification of endothelial cells | |
CA2095153A1 (en) | Genetic modification of endothelial cells | |
WO1988002406A3 (en) | Methods of regulating metabolic stability of proteins | |
EP0330451A3 (en) | A cdna coding for human normal serum albumin a, and a process for production of the albumin | |
NO174351C (no) | Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten | |
EP0859833A4 (en) | RECOMBINANT HEPATITIS C VIRUS REPLICASE | |
DE68918867D1 (de) | Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen. | |
CA2038398A1 (en) | Dna encoding a growth factor specific for epithelial cells | |
ZA943465B (en) | Transforming growth factor alpha H1 | |
EP0424416A4 (en) | Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex | |
WO2000034474A3 (en) | Growth factor homolog zvegf3 | |
ES8506347A1 (es) | Un metodo para producir un polipeptido de tipo il-2-". | |
MY104910A (en) | New derivatives of human/bovine4 basic fibroblast growth factor. | |
Kurobe et al. | Synthesis and secretion of an epidermal growth factor (EGF) by human fibroblast cells in culture | |
NO984491L (no) | SCF-analogpreparater og fremgangsmÕte for fremstilling av disse | |
ES2004099A6 (es) | Procedimiento de preparacion de polipeptidos biologicamente activos | |
ES8605296A1 (es) | Procedimiento de producir factor viii-r humano | |
MXPA01011158A (es) | Factor de crecimiento homologo zvegf4. | |
ZA892518B (en) | Method for the in-vivo production and testing of proteins by recombinant gene expression in selected host-cells | |
IL91475A0 (en) | Production of gonadotropin superagonists by recombinant dna methods and said super agonists produced thereby | |
ATE116366T1 (de) | Verfahren zur herstellung eines menschlichen ''neutrophil chemotactic factor''-polypeptids. | |
HUP9800520A2 (hu) | Génexpresszió emlős sejtekben | |
AU4664489A (en) | Ancrod proteins, their production and use |